Erratum: Pancreatitis potentially associated drugs as a risk factor for post-endoscopic retrograde cholangiopancreatography pancreatitis: A prospective cohort study (Pancreas)

摘要

The authors declare that none of the corrections alter their calculations, results, or conclusions. Changes to the second paragraph of the Results section were changed to reflect the changes in Table 1 shown below:"A quarter of patients did not use any medication during the month before ERCP. Twenty-six patients used medications belonging to class la according to Badalov et al, whereas 21 used only class Ib drugs. Six patients used only class II drugs. Three quarters of the patients used other medications. Six patients used 2 PPADs, and 2 patients used 3 PPADs. Lists of class la, Ib, and II medications used by the patients in total and in cases with PEP are presented in Table 2."